Thrivent Financial for Lutherans’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18.8M | Buy |
|
|||||
|
2025
Q2 | $14.7M | Buy |
|
|||||
|
2025
Q1 | $13.3M | Sell |
|
|||||
|
2024
Q4 | $16.4M | Sell |
|
|||||
|
2024
Q3 | $24.5M | Buy |
|
|||||
|
2024
Q2 | $20.7M | Buy |
|
|||||
|
2024
Q1 | $20M | Sell |
|
|||||
|
2023
Q4 | $70.5M | Sell |
|
|||||
|
2023
Q3 | $100M | Buy |
|
|||||
|
2023
Q2 | $105M | Buy |
|
|||||
|
2023
Q1 | $112M | Sell |
|
|||||
|
2022
Q4 | $206M | Buy |
|
|||||
|
2022
Q3 | $81.7M | Buy |
|
|||||
|
2022
Q2 | $23.3M | Sell |
|
|||||
|
2022
Q1 | $29.8M | Buy |
|
|||||
|
2021
Q4 | $22M | Sell |
|
|||||
|
2021
Q3 | $18.8M | Sell |
|
|||||
|
2021
Q2 | $20.1M | Buy |
|
|||||
|
2021
Q1 | $18.5M | Sell |
|
|||||
|
2020
Q4 | $20.1M | Sell |
|
|||||
|
2020
Q3 | $20.2M | Sell |
|
|||||
|
2020
Q2 | $22.5M | Sell |
|
|||||
|
2020
Q1 | $64.5M | Sell |
|
|||||
|
2019
Q4 | $85.5M | Buy |
|
|||||
|
2019
Q3 | $75.6M | Sell |
|
|||||
|
2019
Q2 | $145M | Buy |
|
|||||
|
2019
Q1 | $136M | Sell |
|
|||||
|
2018
Q4 | $167M | Sell |
|
|||||
|
2018
Q3 | $172M | Sell |
|
|||||
|
2018
Q2 | $142M | Sell |
|
|||||
|
2018
Q1 | $149M | Buy |
|
|||||
|
2017
Q4 | $148M | Buy |
|
|||||
|
2017
Q3 | $144M | Sell |
|
|||||
|
2017
Q2 | $143M | Buy |
|
|||||
|
2017
Q1 | $144M | Sell |
|
|||||
|
2016
Q4 | $149M | Buy |
|
|||||
|
2016
Q3 | $151M | Sell |
|
|||||
|
2016
Q2 | $160M | Sell |
|
|||||
|
2016
Q1 | $136M | Buy |
|
|||||
|
2015
Q4 | $143M | Buy |
|
|||||
|
2015
Q3 | $131M | Buy |
|
|||||
|
2015
Q2 | $137M | Sell |
|
|||||
|
2015
Q1 | $152M | Buy |
|
|||||
|
2014
Q4 | $112M | Buy |
|
|||||
|
2014
Q3 | $97.3M | Sell |
|
|||||
|
2014
Q2 | $109M | Buy |
|
|||||
|
2014
Q1 | $109M | Buy |
|
|||||
|
2013
Q4 | $15.6M | Sell |
|
|||||
|
2013
Q3 | $17.3M | Sell |
|
|||||
|
2013
Q2 | $21.4K | Buy |
|